💊

Drugs Recalls

Prescription and over-the-counter medications

17,685 Total Recalls

Marketed without an Approved NDA/ANDA: Dietary supplement may contain amounts of an active ingredient found in some FDA-approved drugs for erectile dysfunction (ED) making the dietary supplement an unapproved drug.

Sep 27, 2013 Prescription Drugs Nationwide View Details →

Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and phenolphthalein. Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and phenolphthalein. Sibutramine and phenolphthalein are not currently marketed in the United States, making this product an unapproved new drug.

Dec 10, 2013 Prescription Drugs Nationwide View Details →

Penicillin Cross Contamination

Mar 3, 2014 Prescription Drugs Nationwide View Details →

Penicillin Cross Contamination

Mar 3, 2014 Prescription Drugs Nationwide View Details →

Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and phenolphthalein. Sibutramine and phenolphthalein are not currently marketed in the United States, making this product an unapproved new drug.

Dec 10, 2013 Prescription Drugs Nationwide View Details →

Presence of Foreign Tablets/Capsules: Recall is due to a pharmacist complaint of a "foreign material", identified as Metoprolol Tartrate Tablet USP 50 mg, found co-mingled in a bottle of Ranitidine Tablets USP 150 mg.

Mar 18, 2014 Prescription Drugs Nationwide View Details →

Defective Delivery System: Potential for dose delivery out of specification due to interation of the drug product powder with the lubricant on the interior of the capsule shell.

Mar 27, 2014 Prescription Drugs Nationwide View Details →

Penicillin Cross Contamination

Mar 3, 2014 Prescription Drugs Nationwide View Details →